Novel Therapeutic Approaches in IgG4-Related Disease: Focus on Inebilizumab and Pathogenesis-Driven Treatment

Zenodo (CERN European Organization for Nuclear Research) 2026 Preprint Open access

Read full text
Authors: Aris Tsalouchos
DOI: 10.5281/zenodo.18142782
Cited by: 0

Fields of Study & Subjects

IgG4-Related and Inflammatory Diseases Immunodeficiency and Autoimmune Disorders Neuroendocrine Tumor Research Advances

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 January 2026
Document type
Preprint